Clinical Genomics

Selected news for the healthcare topic - Clinical Genomics, collected since 10/2017. This healthcare topic shares news with PierianDx, COVID-19, Precision Medicine, COVID-19 Testing and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
12/23/2021 Global Clinical Genomics Software Market Overview, Size, Share and Trends 2021-2026 blogspot.com This report also researches and evaluates the impact of Covid-19 outbreak on the Clinical Genomics Software industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Clinical Genomics Software and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).GLOBAL INFO RESEARCH indicates that the global Clinical Genomics Software market is expected to surge at ...
11/29/2021 Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry PR Newswire SAN DIEGO , Nov. 29, 2021 /PRNewswire/ -- Agena Bioscience ® (part of Mesa Labs' Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences.This partnership will enable Agena Bioscience to promote and offer its customers the established ...
11/29/2021 Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry uppermichiganssource.com SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Agena Bioscience® (part of Mesa Labs' Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences.This partnership will enable Agena Bioscience to promote and offer its customers the established ...
11/29/2021 Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry | Business | The Daily News galvnews.com SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Agena Bioscience® (part of Mesa Labs' Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences.This partnership will enable Agena Bioscience to promote and offer its customers the established ...
11/29/2021 Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry | News | bakersfield.com bakersfield.com SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Agena Bioscience® (part of Mesa Labs' Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences.This partnership will enable Agena Bioscience to promote and offer its customers the established ...
11/29/2021 Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry continentalnewsshow.com Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics IndustrySAN DIEGO, Nov. 29, 2021 /PRNewswire/ — Agena Bioscience® (part of Mesa Labs’ Clinical Genomics Division), a global provider of genetic…SAN DIEGO, Nov. 29, 2021 /PRNewswire/ — Agena Bioscience® (part of Mesa Labs’ Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with ...
11/29/2021 Agena Bioscience® Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry dailyrecordnews.com SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Agena Bioscience® (part of Mesa Labs' Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences.This partnership will enable Agena Bioscience to promote and offer its customers the established ...
11/29/2021 Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry | Business & Finance citizentribune.com SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Agena Bioscience® (part of Mesa Labs' Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to PGx educational resources. MU is a leading institution providing innovative pharmacogenomic (PGx) educational programs within healthcare and laboratory sciences.This partnership will enable Agena Bioscience to promote and offer its customers the established ...
10/6/2021 Clinical Genomics Announces Expansion of Medicare Coverage Globe Newswire Coverage for traditional Medicare beneficiaries now expanded to Medicare Advantage plan members October 06, 2021 11:30 ET Clinical Genomics Bridgewater, New Jersey, UNITED STATES BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Clinical Genomics , a provider of cancer diagnostic solutions, including liquid biopsy tests for molecular residual disease (“MRD”) and recurrence monitoring of colorectal cancer (“CRC”), announced today that Novitas Solutions Inc. has updated its Local Coverage Determination “Biomarkers ...
10/6/2021 Clinical Genomics Announces Expansion of Medicare Coverage of COLVERA® Liquid Biopsy for Colorectal Cancer Molecular Residual Disease and Recurrence Detection forextv.com Coverage for traditional Medicare beneficiaries now expanded to Medicare Advantage plan members BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) — Clinical Genomics , a provider of cancer diagnostic solutions, including liquid biopsy tests for molecular residual disease (“MRD”) and recurrence monitoring of colorectal cancer (“CRC”), announced today that Novitas Solutions Inc. has updated its Local Coverage Determination “Biomarkers for Oncology” (L35396) to provide coverage for COLVERA®, billed ...
9/15/2021 Mesa Labs agrees to acquire Agena Bioscience for $300m medicaldevice-network.com FDA grants EUA to Cepheid’s rapid Covid-19/Flu/RSV diagnostic test] Mesa Labs agrees to acquire Agena Bioscience for $300m On closing the deal, Agena CEO Peter Dansky will head Mesa’s new Clinical Genomics Division. Mesa Laboratories has signed a definitive agreement to acquire Agena Bioscience for a total of $300m in cash, subject to standard purchase price adjustments. A US-based molecular diagnostics tools company, Agena ...
9/15/2021 Mesa Labs agrees to acquire Agena Bioscience for $300m urallnews.com ... continued natural income development in excessive single digits, with gross revenue margins round $60m, even when Covid-linked revenues cut back. On concluding the acquisition, Agena CEO Peter Dansky will lead the brand new Clinical Genomics Division of Mesa. Dansky stated: “We are happy with our observe file in bringing the facility of genomics to the medical setting in hereditary illnesses, pharmacogenomics, oncology, infectious illness and pattern integrity testing. “We ...
9/14/2021 Colorectal Cancer Diagnosis and Therapeutics Market Size Comprehensive Analysis, Growth Forecast from 2020 to 2025 themarketpublicist.com ... to 2025 and will expected to reach USD million by 2025, from USD million in 2019. The major players covered in Colorectal Cancer Diagnosis and Therapeutics are: - Abbott - Siemens - Volition RX - Beckman Coulter - Novigenix - Clinical Genomics - Metabiomics - Epigenomics - EDP Biotech - Quest Diagnostics Request Sample Copy of this report at https://www.marketstudyreport.com/request-a-sample/2493291?utmsource=marketwatch.com&utmmedium=AG Market segmentation The Colorectal Cancer Diagnosis and Therapeutics market ...
9/14/2021 Mesa Labs Scoops Up Molecular Diagnostics Tools Firm For $300M Benzinga ... first 12 months of ownership. - Agena is also expected to deliver an additional $3 million - $5 million of COVID-19 related revenues. - Peter Dansky, CEO of Agena, will join Mesa to lead the new Clinical Genomics Division. - Mesa plans to complete the transaction in its Q3 ending December 31, 2021. - Mesa expects to finance the all-cash transaction with a combination of cash on hand and proceeds from the credit ...
9/13/2021 Cancer Screening Technology Market Analysis by Current Industry Status and Growth Opportunities, Top Key Players, Target Audience and Forecast to 2027 PRSync Cancer Screening Technology Market Analysis by Current Industry Status and Growth Opportunities, Top Key Players, Target Audience and Forecast to 2027 [reportsandmarkets] [This report studies the Cancer Screening Technology Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Cancer Screening Technology ...
9/2/2021 READ/DOWNLOAD$& Textbook of Veterinary Internal Medicine Expert Consult: Expert Consult, 7e(2 Volume Set) FULL BOOK PDF & FULL AUDIOBOOK | by Cosquilloso5967 | Sep, 2021 | Medium ... for veterinary internal medical problems. The internationally acclaimed “gold standard” offers unparalleled coverage of pathophysiology, diagnosis, and treatment of diseases affecting dogs and cats, as well as the latest information on the genome, clinical genomics , euthanasia, innocent heart murmurs, hyperbaric medicine, home prepared and raw diets, obesity, botulism, artificial pacing of the heart, cancer vaccines, and more. The 7th edition combines the convenience of a two-volume printed textbook ...
8/25/2021 CCMB Hyderabad Project Recruitments [44 Posts] helpbiotech.co.in ... a recognized University or equivalent with 20 years of experience in relevant field. Desirable Qualification: A demonstrable track record of successful implementation/execution of a project in any of the following fields: Population Genomics, Clinical Genomics , Cancer Genomics, De novo Genome assembly, Metagenomics and microbial genomics, Statistical analysis of biological data particularly in the context of Genomics. Experience must be proven either with high impact publications in SCI-indexed journals ...
8/23/2021 Anal and Colorectal Cancer Market Research & Clinical Advancements by 2025 | Abbott Diagnostics, Advaxis monroescoop.com ... you competition analysis of top manufacturer with sales volume, price, revenue (Million USD) and market share, the top players including Abbott Diagnostics, Advaxis, Alere, Amgen, Atara Biotherapeutics, Bayer, Metabiomics, Beckman Coulter, BeiGene, Boehringer Ingelheim, Clinical Genomics , EDP Biotech, Eli Lilly, Epigenomics, Exact Sciences, Genomictree, Immunovaccine, ISA Pharmaceuticals, Merck. Get the inside scoop of the Sample report @: www.statsandreports.com/request-sample/314087-global-anal-and-colorectal-cancer-market-size-status-and-forecast ...
8/23/2021 New Report Unveils more details about Colorectal Cancer Diagnosis and Therapeutics Market by 2027 | Abbott, Beckman Coulter, Clinical Genomics themarketwriteup.com ... major reason for the expansion of this market. Get Sample Report with Latest Industry Trends Analysis: https://www.a2zmarketresearch.com/sample?reportId=87273 Some of the Top companies Influencing in this Market includes: Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens, Quest Diagnostics, Metabiomics. Various factors are responsible for the market’s growth trajectory, which are studied at length in the report. In addition, the report lists down ...
8/23/2021 Linking common human diseases to their phenotypes; development of a resource for human phenomics biomedcentral.com Linking common human diseases to their phenotypes; development of a resource for human phenomics 17 (2021) Cite this article 4 Accesses - Abstract Background In recent years a large volume of clinical genomics data has become available due to rapid advances in sequencing technologies. Efficient exploitation of this genomics data requires linkage to patient phenotype profiles. Current resources providing disease-phenotype associations are not comprehensive, and they often do not ...